Cargando…
Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report
Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMCT) is a recently described entity with only 13 cases reported in the literature. Histopathologically, the neoplasm consists of atypical epithelioid to spindled cells that form a well‐circumscribed nodule usually confined to the dermis and sub...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086857/ https://www.ncbi.nlm.nih.gov/pubmed/35751643 http://dx.doi.org/10.1111/cup.14287 |
_version_ | 1785022234117537792 |
---|---|
author | Vest, Blake E. Harview, Christina L. Liu, Vincent Swick, Brian L. Berrebi, Kristen G. Olivares, Shantel Stone, Mary S. Sargen, Michael R. Gerami, Pedram |
author_facet | Vest, Blake E. Harview, Christina L. Liu, Vincent Swick, Brian L. Berrebi, Kristen G. Olivares, Shantel Stone, Mary S. Sargen, Michael R. Gerami, Pedram |
author_sort | Vest, Blake E. |
collection | PubMed |
description | Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMCT) is a recently described entity with only 13 cases reported in the literature. Histopathologically, the neoplasm consists of atypical epithelioid to spindled cells that form a well‐circumscribed nodule usually confined to the dermis and subcutis with cytological features including large vesicular nuclei with prominent nucleoli and abundant eosinophilic cytoplasm. Immunohistochemistry shows variable expressivity of melanocytic markers. Currently, there are limited data regarding long‐term outcomes of this newly described entity. Most cases have done well, but there is one case reported with an adverse event. Hence, further studies are needed to accurately classify this tumor. Definitive diagnosis is made by laboratory evidence of CMCT. Herein, we report the first case of CMCT with epidermal involvement in the youngest patient known to be affected to date. |
format | Online Article Text |
id | pubmed-10086857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Blackwell Publishing Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100868572023-04-12 Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report Vest, Blake E. Harview, Christina L. Liu, Vincent Swick, Brian L. Berrebi, Kristen G. Olivares, Shantel Stone, Mary S. Sargen, Michael R. Gerami, Pedram J Cutan Pathol Case Studies Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion (CMCT) is a recently described entity with only 13 cases reported in the literature. Histopathologically, the neoplasm consists of atypical epithelioid to spindled cells that form a well‐circumscribed nodule usually confined to the dermis and subcutis with cytological features including large vesicular nuclei with prominent nucleoli and abundant eosinophilic cytoplasm. Immunohistochemistry shows variable expressivity of melanocytic markers. Currently, there are limited data regarding long‐term outcomes of this newly described entity. Most cases have done well, but there is one case reported with an adverse event. Hence, further studies are needed to accurately classify this tumor. Definitive diagnosis is made by laboratory evidence of CMCT. Herein, we report the first case of CMCT with epidermal involvement in the youngest patient known to be affected to date. Blackwell Publishing Ltd. 2022-08-04 2022-12 /pmc/articles/PMC10086857/ /pubmed/35751643 http://dx.doi.org/10.1111/cup.14287 Text en © 2022 The Authors. Journal of Cutaneous Pathology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Studies Vest, Blake E. Harview, Christina L. Liu, Vincent Swick, Brian L. Berrebi, Kristen G. Olivares, Shantel Stone, Mary S. Sargen, Michael R. Gerami, Pedram Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report |
title | Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report |
title_full | Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report |
title_fullStr | Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report |
title_full_unstemmed | Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report |
title_short | Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report |
title_sort | cutaneous melanocytic tumor with crtc1::trim11 fusion and prominent epidermal involvement: a case report |
topic | Case Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086857/ https://www.ncbi.nlm.nih.gov/pubmed/35751643 http://dx.doi.org/10.1111/cup.14287 |
work_keys_str_mv | AT vestblakee cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport AT harviewchristinal cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport AT liuvincent cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport AT swickbrianl cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport AT berrebikristeng cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport AT olivaresshantel cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport AT stonemarys cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport AT sargenmichaelr cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport AT geramipedram cutaneousmelanocytictumorwithcrtc1trim11fusionandprominentepidermalinvolvementacasereport |